Want to join the conversation?
$AMGN said it plans to submit data from Phase 3 endeavor trial for potential authorization of the Kyprolis drug in combination with dexamethasone in the EU. This data serves as basis of supplemental NDA of Kyprolis in combination with dexamethasone for patients with relapsed multiple myeloma, which has been accepted for priority review by US FDA.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.